Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Vildagliptin, a DPP-4 Inhibitor, in Elderly Diabetic Patients With Mild Cognitive Impairment

NCT03819127 is registered in ClinicalTrials.gov with University of Catania as lead sponsor.

NCT NCT03819127
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03819127 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Vildagliptin, a DPP-4 Inhibitor, in Elderly Diabetic Patients With Mild Cognitive Impairment
Lead sponsor
University of Catania
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2015
Completion date
September 30, 2016
Enrollment
60 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

mild cognitive impairment